Summary
The Randomized Evaluation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent [EVOLVE] trial compared the bioabsorbable polymer SYNERGY Everolimus-Eluting Coronary Stent System with the permanent polymer PROMUS Element Stent for the treatment of de novo atherosclerotic lesions.
- Interventional Techniques & Devices
- Cardiology Clinical Trials
- © 2011 MD Conference Express